Boris Hadaschik | IKIM MMLhttps://mml.kite.ume.de/authors/boris-hadaschik/Boris HadaschikHugoBlox Kit (https://hugoblox.com)en-usFri, 01 May 2026 00:00:00 +0000https://mml.kite.ume.de/media/authors/boris-hadaschik_hu_e86cf1da27d002d7.jpgBoris Hadaschikhttps://mml.kite.ume.de/authors/boris-hadaschik/Salvage Radiotherapy Confers an Overall Survival Advantage in Biochemical Recurrence of Prostate Cancer: Evidence from the International PROMISE Registryhttps://mml.kite.ume.de/publications/guberina-salvage-2026/Fri, 01 May 2026 00:00:00 +0000https://mml.kite.ume.de/publications/guberina-salvage-2026/Explainable AI Predicts Hematoxicity from Cancer Treatment Using Multimodal Real-World Datahttps://mml.kite.ume.de/publications/keyl-explainable-2026/Wed, 01 Apr 2026 00:00:00 +0000https://mml.kite.ume.de/publications/keyl-explainable-2026/Leveraging Sarcopenia index by automated CT body composition analysis for pan cancer prognostic stratificationhttps://mml.kite.ume.de/publications/borys-leveraging-2025/Wed, 01 Oct 2025 00:00:00 +0000https://mml.kite.ume.de/publications/borys-leveraging-2025/Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligencehttps://mml.kite.ume.de/publications/keyl-decoding-2025/Sat, 01 Feb 2025 00:00:00 +0000https://mml.kite.ume.de/publications/keyl-decoding-2025/Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective studyhttps://mml.kite.ume.de/publications/karpinski-combining-2024/Sun, 01 Sep 2024 00:00:00 +0000https://mml.kite.ume.de/publications/karpinski-combining-2024/Establishing Medical Intelligence - Leveraging FHIR to Improve Clinical Management: a retrospective cohort and clinical implementation studyhttps://mml.kite.ume.de/publications/brehmer-establishing-2024/Thu, 01 Aug 2024 00:00:00 +0000https://mml.kite.ume.de/publications/brehmer-establishing-2024/Tumor likelihood estimation on MRI prostate data by utilizing k-Space informationhttps://mml.kite.ume.de/publications/rempe-tumor-2024/Sat, 01 Jun 2024 00:00:00 +0000https://mml.kite.ume.de/publications/rempe-tumor-2024/Characteristics and outcomes of patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with lutetium-177–PSMA-617 (PSMA-RLT) in a real-world setting.https://mml.kite.ume.de/publications/kersting-characteristics-2024/Thu, 01 Feb 2024 00:00:00 +0000https://mml.kite.ume.de/publications/kersting-characteristics-2024/Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligencehttps://mml.kite.ume.de/publications/keyl-decoding-2023/Sun, 01 Oct 2023 00:00:00 +0000https://mml.kite.ume.de/publications/keyl-decoding-2023/Intraoperative Molecular Positron Emission Tomography Imaging for Intraoperative Assessment of Radical Prostatectomy Specimenshttps://mml.kite.ume.de/publications/darr-intraoperative-2023/Tue, 01 Aug 2023 00:00:00 +0000https://mml.kite.ume.de/publications/darr-intraoperative-2023/Establishing Medical Intelligence - Leveraging FHIR to Improve Clinical Managementhttps://mml.kite.ume.de/publications/brehmer-establishing-2023/Thu, 01 Jun 2023 00:00:00 +0000https://mml.kite.ume.de/publications/brehmer-establishing-2023/Virtual Biopsy: Just an AI Software or a Medical Procedure?https://mml.kite.ume.de/publications/murray-virtual-2022/Tue, 01 Feb 2022 00:00:00 +0000https://mml.kite.ume.de/publications/murray-virtual-2022/PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysishttps://mml.kite.ume.de/publications/seifert-psma-2020/Tue, 01 Sep 2020 00:00:00 +0000https://mml.kite.ume.de/publications/seifert-psma-2020/